default author photo

Lesley Fallowfield

Sussex Health Outcomes Research & Education in Cancer (SHORE-C)

SCHOLARLY PAPERS

3

DOWNLOADS

228

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Estimating the Ovarian Cancer CA-125 Preclinical Detectable Phase, In-Vivo Tumour Doubling Time, and Window for Detection in Early Stage: An Exploratory Analysis of UKCTOCS

Number of pages: 44 Posted: 22 May 2024
Harvard University - Massachusetts General Hospital, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, Queen Mary University of London - Wolfson Institute of Population Health, Imperial College London - AGE Research Unit, University College London, Department of Clinical Biochemistry, Sussex Health Outcomes Research & Education in Cancer (SHORE-C), London School of Economics & Political Science (LSE), Create Health Ltd, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit and Harvard University - Massachusetts General Hospital
Downloads 123 (584,619)

Abstract:

Loading...

CA-125 Antigen / blood, Carcinoma, Ovarian Epithelial*, Early Detection of Cancer*, Longitudinal Studies, Ovarian Neoplasms* / epidemiology, UKCTOCS, Mass Screening, biomarker, Preclinical history of cancer / preclinical detectable phase / natural history of cancer, Early Diagnosis

2.

Why Did Downstaging in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Not Result in a Mortality Benefit: Exploratory Analysis of a Randomised Controlled Trial

Number of pages: 25 Posted: 27 May 2023
University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, Barts Health NHS Trust, Department of Cellular Pathology, Queen Mary University of London - Wolfson Institute of Population Health, Imperial College London - AGE Research Unit, Government of the United Kingdom - Department of Gynaecological Oncology, University College London - Department of Cellular Pathology, Barts Health NHS Trust, Department of Cellular Pathology, University College London, Department of Clinical Biochemistry, Cardiff and Vale University Health Board - Department of Obstetrics and Gynaecology, University of Nottingham - Department of Gynaecological Oncology, University College London - MRC Clinical Trials Unit, Sussex Health Outcomes Research & Education in Cancer (SHORE-C), London School of Economics & Political Science (LSE), Create Health Ltd, Harvard University - Massachusetts General Hospital, University College London - MRC Clinical Trials Unit and University College London - MRC Clinical Trials Unit
Downloads 74 (844,901)

Abstract:

Loading...

ovarian cancer, tubo-ovarian high grade serous cancer, UKCTOCS, screening, survival

3.

Biomarker recall and understanding among people living with metastatic breast cancer – results from an international patient survey

Number of pages: 28 Posted: 09 Jan 2026
affiliation not provided to SSRN, affiliation not provided to SSRN, Sussex Health Outcomes Research & Education in Cancer (SHORE-C), University of Miami, Breast Cancer Network Australia, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 31 (1,318,317)

Abstract:

Loading...

metastatic breast cancer, Biomarker, Subtype, Patient Survey, shared decision-making